Algemeen nieuws

Algemeen nieuws

The true age of your blood vessels reveals the risk of further cardiovascular diseases

Researcher does lab research.

We all have that one friend who never seems to age. But did you know this phenomenon is visible not only on the outside but also deep within our blood vessels? This biological ageing caught the attention of Ernest Diez Benavente, PhD, from the Department of Experimental Cardiology at UMC Utrecht. His new research shows that the biological age of our blood vessels plays a significant role in the development of future cardiovascular diseases.

Read more

Jaap Trappenburg appointed EWUU Alliance Coordinator

Jaap Trappenburg, EWUU Alliance Coordinator

The Board of the EWUU alliance between Eindhoven University of Technology, Wageningen University & Research, Utrecht University and University Medical Centre Utrecht has decided to appoint Jaap Trappenburg to the position of Alliance Coordinator as of 12 August.

Read more

Cullen lecture: loose ends in transfer

Patient sits in her living room while telling her story.

Transfer from one organization or health care provider to another is a well-known high-risk moment in patients' care journey. How do we prevent loose ends when transferring patients in the care network so that continuity of care is not compromised? That was the subject of the sixth Adrienne Cullen Lecture this week at the UMC Utrecht, with the theme ‘Switching smoothly’: how do we avoid loose ends when transferring patients in the care network’.

Read more

Patricia Bruijning-Verhagen appointed professor of vaccination and infection control epidemiology

Portrait picture of Patricia Bruijning, professor of vaccination and infection control epidemiology

Utrecht University and UMC Utrecht have announced the appointment of Patricia Bruijning-Verhagen as professor of vaccination and infection control epidemiology, effective June 1, 2024. This position will enable Patricia to continue her work in designing and evaluating optimal infection prevention policies through vaccination and other innovative strategies. Her appointment comes at a crucial time, as the world faces the dual challenge of emerging infectious diseases and an expanding portfolio of vaccines.

Read more

Unique trial patients with CF: customisation with organoids

Dilara Vilic and Kors van der Ent are in conversation in a hospital room.

Dilara Vilic is the first European patient with Cystic Fibrosis (CF) to participate in a unique clinical trial at the Wilhelmina Children's Hospital in Utrecht. For the clinical trial, patients are selected for the first time with the Utrecht CF organoid model.

Read more

Kidney tumors in children: specific diagnosis with MRI

Researcher Justine van der Beek with her publication in front of the WKZ.

Justine van der Beek researched how different types of kidney tumors can be distinguished using MRI scans.

Read more

World-class collaboration receives €37.5 million for regenerative medicine using smart materials

Researcher with a pincet and test tube.

Read more

Jeroen Pasterkamp member of Academia Europaea

Portrait picture of Jeroen Pasterkamp.

Jeroen Pasterkamp, professor of Translational Neuroscience and scientific director of the UMC Utrecht Brain Center, has been appointed a member of the Academia Europaea. That is the European society of scientists belonging to the global top. The appointment is a tribute to Jeroen's groundbreaking research and leadership in the neuroscience field.

Read more

Alternatives to antibiotics: Adapting phages to overcome bacterial defense barriers

3D rendering of bacteriophage

Collaborating researchers from University Medical Center Utrecht and Delft University of Technology have received funding from the Dutch Research Council (NWO) to develop more broadly acting bacteriophages. With help of such adapted phages, the researchers want to overcome bacterial defense barriers, which are important mechanisms in the bacterial resistance against bacteriophages.

Read more

Study of new treatment for severe influenza pneumonia

Van elke vijf patiënten die met ernstige longontsteking door influenza op de intensive care (IC) worden opgenomen, overlijdt er gemiddeld één. Om dit relatief hoge risico op overlijden te verlagen, gaan Nederlandse onderzoekers onder leiding van UMC Utrecht geneesmiddelen die eerder succesvol waren bij de behandeling van patiënten met ernstige Covid-19 op de IC terecht kwamen, nu ook onderzoeken bij IC-patiënten met ernstige longontsteking door influenza. ZonMw heeft voor deze studie een subsidie van ruim € 2.1 miljoen beschikbaar gesteld.

Read more

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not